D0060-319
/ Easton Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 27, 2023
Examination of in vitro and in vivo antitumor activity of Menin-MLL inhibitor, D0060-319.
(ASCO 2023)
- "In MLL-rearranged leukemia, D0060-319 showed high antitumor activity and good tolerability both in vitro and in vivo."
Preclinical • Hematological Malignancies • Leukemia • Oncology • KMT2A • MEN1
May 26, 2023
"https://t.co/jbk7qkDppJ ➡️ Another menin inhibitor: Examination of in vitro and in vivo antitumor activity of Menin-MLL inhibitor, D0060-319 #ASCO23"
(@TalhaBadarMD)
Preclinical • Oncology
1 to 2
Of
2
Go to page
1